Clinical Trial Update: Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ropinirole extended-release tablets as monotherapy for Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ropinirole PR/XR (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-12-23